Home » Topics » BioWorld Science

BioWorld Science
RSS

Extension of Neuro3d's research collaboration with Johnson & Johnson

July 23, 2004

Roche seeks U.S. and E.U. approval for Pegasys in hepatitis B

July 23, 2004

Oral bioavailability of alphaHGA demonstrated

July 23, 2004

Statistically significant increase in growth rate at six months in SomatoKine study

July 23, 2004

Plan established with FDA for sBLA filing for Erbitux

July 23, 2004

Significant survival benefit in A-HeFT study of BiDil brings early conclusion

July 23, 2004

Pharmacokinetic profile of IAalpha5-2 in healthy volunteers

July 23, 2004

PT-141 increases sexual behavior in female rats

July 23, 2004

6R-BH4 reported to decrease serum phenylalanine levels in PKU patients

July 23, 2004

Suppression of HIV-1 viral replication by p38 MAPK inhibitor

July 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....